Pharmalundensis
Manufacturing · Sweden · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Scheelevagen 2, Lund, Skane, SE-223 81, ...Phone Number
+46 46132780Website
www.pharmalundensis.seRevenue
<$5 MillionIndustry
About Pharmalundensis
Is Pharmalundensis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Pharmalundensis launches new products
Earning: See what the market has to say on Pharmalundensis recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Pharmalundensis
Click to see if Pharmalundensis had a recent Job posting/layoffs
Check if Pharmalundensis has recently received funding, and reach out quickly before it becomes old news!
Check out if Pharmalundensis is spiking on competitors!
Pharmalundensis, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Pharmalundensis has new funding data
Recommended Actions
Reach out to Masked Content who joined Pharmalundensis as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Pharmalundensis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pharmalundensis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pharmalundensis.
Pharmalundensis Tech Stack
A closer look at the technologies used by Pharmalundensis
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pharmalundensis
PharmaLundensis develops pharmaceuticals that bind and excrete heavy metals such as mercury, lead, and cadmium from the body, aiming to improve health in various diseases. Their lead product, Phal-501, is expected to be an effective antidote for methylmercury, a potent neurotoxin found in contaminated food sources. The company targets patients suff... Read More